Cargando…

Timing of cognitive decline in CLN3 disease

BACKGROUND: CLN3 disease is a major cause of childhood neurodegeneration. Onset of visual failure around 6 years of age is thought to precede cognitive deterioration by a few years, but casuistic reports question this paradigm. The aim of our study is to delineate timing of cognitive decline in CLN3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuper, Willemijn F. E., van Alfen, Claudia, Rigterink, Roeliene H., Fuchs, Sabine A., van Genderen, Maria M., van Hasselt, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830481/ https://www.ncbi.nlm.nih.gov/pubmed/29392585 http://dx.doi.org/10.1007/s10545-018-0143-x

Ejemplares similares

The c.1A > C start codon mutation in CLN3 is associated with a protracted disease course
por: Kuper, Willemijn F. E., et al.
Publicado: (2020)

Recognizing differentiating clinical signs of CLN3 disease (Batten disease) at presentation
por: Kuper, Willemijn F. E., et al.
Publicado: (2020)

Quantifying lymphocyte vacuolization serves as a measure of CLN3 disease severity
por: Kuper, Willemijn F. E., et al.
Publicado: (2020)

Towards Understanding Behaviour and Emotions of Children with CLN3 Disease (Batten Disease): Patterns, Problems and Support for Child and Family
por: Honingh, Aline K., et al.
Publicado: (2022)

Automatic quantification of lymphocyte vacuolization in peripheral blood smears of patients with Batten's disease (CLN3 disease)
por: Nonkes, Lourens J. P., et al.
Publicado: (2021)

Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis
por: Gomez-Giro, Gemma, et al.
Publicado: (2019)

Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
por: Soldati, Chiara, et al.
Publicado: (2021)

Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin
por: Minye, Helena M., et al.
Publicado: (2016)

Glycerophosphoinositol is Elevated in Blood Samples From CLN3(Δex7-8) pigs, Cln3(Δex7-8) Mice, and CLN3-Affected Individuals
por: Brudvig, Jon J, et al.
Publicado: (2022)

Phenotypic variant of CLN3 mutation
por: Honasoge, Avinash, et al.
Publicado: (2022)

A tailored Cln3(Q352X) mouse model for testing therapeutic interventions in CLN3 Batten disease
por: Langin, Logan, et al.
Publicado: (2020)

in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels
por: Mohammed, Alamin, et al.
Publicado: (2017)

Loss of Cln3 Function in the Social Amoeba Dictyostelium discoideum Causes Pleiotropic Effects That Are Rescued by Human CLN3
por: Huber, Robert J., et al.
Publicado: (2014)

A comparative study of the degradation of yeast cyclins Cln1 and Cln2
por: Quilis, Inma, et al.
Publicado: (2016)

The CLN3 gene and protein: What we know
por: Mirza, Myriam, et al.
Publicado: (2019)

Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients
por: Makoukji, Joelle, et al.
Publicado: (2015)

Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses
por: Russell, Katharina N., et al.
Publicado: (2021)

FRET-Assisted Determination of CLN3 Membrane Topology
por: Ratajczak, Ewa, et al.
Publicado: (2014)

Exogenous Flupirtine as Potential Treatment for CLN3 Disease
por: Maalouf, Katia, et al.
Publicado: (2020)

Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis
por: Murray, Samantha J, et al.
Publicado: (2023)

Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses
por: Murray, S. J., et al.
Publicado: (2022)

Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
por: Specchio, Nicola, et al.
Publicado: (2020)

Plasma Neurofilament Light Is Not Associated with Ongoing Neuroaxonal Injury or Cognitive Decline in Perinatally HIV Infected Adolescents: A Brief Report
por: van der Post, Julie, et al.
Publicado: (2022)

Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system
por: Klein, Marcel, et al.
Publicado: (2021)

Glucose transporter type 1 deficiency syndrome and the ketogenic diet
por: Schwantje, Marit, et al.
Publicado: (2019)

Invited editorial in regards to phenotypic variant of CLN3 mutation
por: Honasoge, Avinash, et al.
Publicado: (2022)

Efficacy of phosphodiesterase‐4 inhibitors in juvenile Batten disease (CLN3)
por: Aldrich, Amy, et al.
Publicado: (2016)

Early recognition of CLN3 disease facilitated by visual electrophysiology and multimodal imaging
por: Sakti, Dhimas H., et al.
Publicado: (2023)

Clinical management and diagnosis of CLN2 disease: consensus of the Brazilian experts group
por: Sampaio, Leticia Pereira de Brito, et al.
Publicado: (2023)

The Batten disease gene CLN3 is required for the response to oxidative stress
por: Tuxworth, Richard I., et al.
Publicado: (2011)

Autophagic vacuolar myopathy is a common feature of CLN3 disease
por: Radke, Josefine, et al.
Publicado: (2018)

Beyond nephronophthisis: Retinal dystrophy in the absence of kidney dysfunction in childhood expands the clinical spectrum of CEP83 deficiency
por: Veldman, Bram C. F., et al.
Publicado: (2021)

The timing of Start is determined primarily by increased synthesis of the Cln3 activator rather than dilution of the Whi5 inhibitor
por: Litsios, Athanasios, et al.
Publicado: (2022)

Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease
por: Mitchell, Nadia L., et al.
Publicado: (2023)

CLN7 gene therapy: hope for an ultra-rare condition
por: Brudvig, Jon J., et al.
Publicado: (2022)

The Batten disease protein CLN3 is important for stress granules dynamics and translational activity
por: Relton, Emily L., et al.
Publicado: (2023)

Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease)
por: Wager, Kim, et al.
Publicado: (2016)

Neurofilament Light Chain Levels Correlate with Clinical Measures in CLN3 Disease
por: Dang Do, An N., et al.
Publicado: (2020)

CLN8 is an ER cargo receptor that regulates lysosome biogenesis
por: di Ronza, Alberto, et al.
Publicado: (2018)

Searching for novel biomarkers using a mouse model of CLN3-Batten disease
por: Timm, Derek, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f83j7i1ek74jasis7ld4ros4ok